Another study evaluating serum MMP9 levels in 88 sarcopenic patients aged 65 and over showed that serum MMP9/tissue inhibitor of metalloproteinase 1 (TIMP1) had similar performance as a sarcopenia biomarker to the SARC-F questionnaire (AUC = 0.67) [88]. The gene discussed is MMP9; the disease is sarcopenia.